Innocare Pharma Limited Announces Executive Changes
Mr. Jin,
has been an investment director of Hankang Capital since
2017 and was promoted to managing director and partner thereof in 2018 and 2020, respectively.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 HKD | -0.44% | -11.05% | -34.54% |
16/05 | InnoCare Pharma Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis | CI |
14/05 | Innocare Pharma Posts Q1 Loss | MT |
1st Jan change | Capi. | |
---|---|---|
-34.54% | 1.14B | |
+10.58% | 118B | |
+10.37% | 106B | |
-11.29% | 23.4B | |
-1.86% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-14.88% | 15.97B | |
+6.41% | 14.03B | |
+14.49% | 11.67B |